The planned report of RFK Jr. connecting Tylenol to autism plants actions of the parent company Kenvue

The Secretary of Health and Social Services, Robert F. Kennedy Jr., prepares a report that allegedly claimed a link between the prenatal use of Tylenol (acetaminophen) and autism, but current evidence does not support a causal relationship, and the main medical groups continue to recommend a prudent use of acetaminophen during pregnancy when indicated; Meanwhile, the actions of the parent of Tylenol Kenvue sold strongly following reports and remain volatile.
What is in the planned report
- Several points of sale report that the next HHS autism report led by Robert F. Kennedy Jr. should suggest that the use of acetaminophen during pregnancy is linked to autism and highlights low folate levels, while pointing folinic acid (Leucovorin) as a potential means of reducing symptoms for some people with the familiarity with the familiarity with the people with the people Project quoted by means on the part of The Postom Way to reduce the symptoms for some people with autism, according to people familiar with the project cited by means on the part of The Postom Way to the Trew Wall Street JournalWhat was the first to point out the news.
- HHS said that the conclusions should not be supposed before the final report, and Kenvue said that he had continuously examined science and saw no causal link between the use of acetaminophen during pregnancy and autism.
Reculations spent on autism
- Good fortune Contextualized the wider statements of RFK Jr. by signaling its concentration on “environmental toxins” as key motors in the increase in autism diagnoses, supervising its affirmations in the midst of scientific uncertainty on specific non -genetic causes.
- Good fortune Also examined the anterior “Maha report” of RFK Jr., indicating that he cited studies nonexistent or misinterpreted, signaling problems of rigor and interpretation likely to shape the reception of any new affirmation concerning acetaminophen.
What science says
- A very large JAMA 2024 study of nearly 2.5 million Swedish children, using analyzes of control of brothers and sisters to take into account family confusion, found no association between prenatal exposure to acetaminopène and the diagnoses of autism, ADHD or intellectual impairment, an observation also summarized by groups of NIH and plea.
- Conventional adjusted models often have small associations, but they are probably explained by unbeatable factors; In the JAMA study, the slight elevation of the risk has disappeared in the analyzes of brothers and sisters, while an earlier meta-analysis without witnesses of brothers and sisters reported ~ 19% of higher ratings for the symptoms of autism and ~ 21% for the symptoms of ADHD, illustrating how confusion can influence the results.
- The main professional societies (ACOG and SMFM) continue to recommend acetaminophen as a first line option for pain and fever during pregnancy when they are medically indicated, at the lowest dose for the shortest necessary time, and they do not recommend a change of practice depending on the current evidence.
- A declaration of consensus “precaution” in 2021 expressed caution with acetaminophen during pregnancy, but ACOG and other groups replied that causal proofs are low and do not justify the modification of clinical advice, emphasizing the difference between association signals and proof of cause.
Kenvue stock reaction
- The reports according to which the next HHS document of RFK Jr. will link Tylenol during autism pregnancy have triggered a net in Kenvue shares, with coverage noting that drops of more than 6% and a session in particular for stock when it dropped by more than 14% before the loss of payroll.
- Additional points of sale have stressed that Kenvue was among the most active market movers as the news, and global coverage described the actions of the company as “hit” following the chatter of the report.
- Recent commercial data show large intra -day swings and a heavy volume with consequences, with a range of days that has captured a deep fall and partial recovery, highlighting continuous volatility rather than an established trend.
- The planned report should affirm a bond of acetaminophen-autism, but the strongest recent evidence does not support causality, and the main medical organizations always approve of prudence, an indicated use of acetaminophen during pregnancy; Kenvue’s stock was under pressure in the middle of the titles and remains volatile.
For this story, Fortune Used a generative AI to help an initial project. An editor checked the accuracy of the information before the publication.
Global Forum fortune returns on October 26 to 27, 2025 in Riyadh. CEOs and world leaders will meet for a dynamic event only invitation that shapes the future of business. Request an invitation.
https://fortune.com/img-assets/wp-content/uploads/2025/09/GettyImages-2233689729.jpg?resize=1200,600